|
|
|
Insider
Information: |
Makower Joshua |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
19 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
121,909,609 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$396,036,358 |
|
|
Total
Shares |
121,909,609 |
|
|
Total
Value |
$396,036,358 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
14.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
|
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2020-06-19 |
3,952,958 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2020-07-24 |
10,376,936 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2020-04-03 |
5,937,998 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
4,186,243 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2020-06-30 |
4,294,207 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2020-09-18 |
3,060,527 |
Premium* |
|
Eargo, Inc. |
EAR |
Director, 10% Owner |
2020-10-20 |
0 |
2021-05-24 |
508 |
Premium* |
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
|
0 |
2021-06-08 |
2,285 |
Premium* |
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2021-03-15 |
24,137,931 |
Premium* |
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
75 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-16 |
4 |
B |
$1.86 |
$649,355 |
I/I |
350,000 |
19,388,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-19 |
4 |
B |
$1.88 |
$956,658 |
I/I |
510,000 |
19,898,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-20 |
4 |
B |
$1.98 |
$336,107 |
I/I |
170,000 |
20,068,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-28 |
4 |
B |
$1.99 |
$48,824 |
I/I |
24,500 |
20,092,538 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-11-30 |
4 |
B |
$1.98 |
$142,067 |
I/I |
71,900 |
20,164,438 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-06 |
4 |
B |
$1.99 |
$54,414 |
I/I |
27,300 |
20,191,738 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-07 |
4 |
B |
$1.98 |
$232,362 |
I/I |
117,100 |
20,308,838 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-10 |
4 |
B |
$1.98 |
$51,576 |
I/I |
26,000 |
20,334,838 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-11 |
4 |
B |
$1.98 |
$121,084 |
I/I |
61,200 |
20,396,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-20 |
4 |
B |
$1.63 |
$326,060 |
I/I |
200,000 |
20,596,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-21 |
4 |
B |
$1.49 |
$448,380 |
I/I |
300,000 |
20,896,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2019-04-08 |
4 |
B |
$1.14 |
$4,956,523 |
I/I |
4,347,827 |
25,243,865 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2020-06-19 |
4 |
B |
$5.25 |
$7,499,998 |
I/I |
1,428,571 |
3,952,958 |
1.5 |
% |
|
BHG |
Bright Health Group Inc. |
10% Owner |
|
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
46,859,421 |
|
- |
|
BHG |
Bright Health Group Inc. |
10% Owner |
|
2021-06-28 |
4 |
B |
$18.00 |
$34,999,992 |
I/I |
1,944,444 |
23,983,073 |
1.5 |
% |
|
BHG |
Bright Health Group Inc. |
10% Owner |
|
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
133,640,415 |
22,288,629 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
10% Owner |
|
2017-01-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,064,574 |
|
- |
|
CASC |
Cascadian Therapeutics, I... |
10% Owner |
|
2018-02-20 |
4 |
OE |
$3.30 |
$5,999,400 |
I/I |
1,818,000 |
10,882,574 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
10% Owner |
|
2018-03-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,882,574) |
0 |
0 |
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2020-12-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
28,398,927 |
|
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2021-06-08 |
4 |
A |
$0.00 |
$0 |
I/I |
137,285 |
2,285 |
0 |
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2021-06-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(9,135,000) |
0 |
0 |
- |
|
EAR |
Eargo, Inc. |
Director |
|
2020-10-20 |
4 |
B |
$18.00 |
$5,599,998 |
I/I |
311,111 |
6,520,017 |
2.25 |
- |
|
EAR |
Eargo, Inc. |
Director |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
6,208,906 |
6,208,906 |
0 |
- |
|
EAR |
Eargo, Inc. |
Director |
|
2021-05-24 |
4 |
A |
$0.00 |
$0 |
I/I |
30,508 |
508 |
0 |
- |
|
75 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|